Product Information
NARATRIPTAN HCL 2.5 MG TABLET is a generic product labeled by Bionpharma Inc., priced at $1.0835 per EA under NDC 69452034172. Its NADAC has been published 221 times since Jul 13, 2022.
FDA first approved this application on Apr 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Bionpharma Inc.NDC
69452034172
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NARATRIPTAN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091441FDA Approved
4/30/2012
TE Code
AB
On Market Since
4/11/2022
Pharmacological Classes
Price Statistics
The NADAC for NARATRIPTAN HCL 2.5 MG TABLET has been published 221 times since Jul 13, 2022, and over the history we have for it it has declined 42.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0835 per EA |
|---|---|
| All-time high | $1.8966 (Jul 13, 2022) |
| All-time low | $0.8797 (Nov 20, 2024) |
| 52-week high | $1.2118 |
| 52-week low | $1.0329 |
| Median price | $1.3106 |
| Average price | $1.3013 |
| Largest weekly change | +37.3% (Aug 21, 2024) |
| Weeks tracked | 221 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bionpharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naratriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NARATRIPTAN HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NARATRIPTAN HCL 2.5 MG TABLET, manufactured by Bionpharma Inc., is $1.0835 per EA (NDC 69452034172), effective Sep 30, 2026.
How has the price of NARATRIPTAN HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for NARATRIPTAN HCL 2.5 MG TABLET has declined 42.9%. It has been tracked across 221 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for NARATRIPTAN HCL 2.5 MG TABLET?
Since Jul 13, 2022, the NADAC for NARATRIPTAN HCL 2.5 MG TABLET has ranged from a low of $0.8797 (Nov 20, 2024) to a high of $1.8966 (Jul 13, 2022), with a median of $1.3106 per EA.
Are there cheaper alternatives to NARATRIPTAN HCL 2.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NARATRIPTAN HCL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NARATRIPTAN HCL 2.5 MG TABLET?
NARATRIPTAN HCL 2.5 MG TABLET (NDC 69452034172) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.